Raleigh Capital Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,728
| Closed | -$52K | – | 1006 |
|
|
2024
Q4 | $52K | Hold |
1,728
| – | – | 0.02% | 312 |
|
|
2024
Q3 | $40.4K | Hold |
1,728
| – | – | 0.02% | 348 |
|
|
2024
Q2 | $30.7K | Hold |
1,728
| – | – | 0.01% | 367 |
|
|
2024
Q1 | $26.3K | Buy |
1,728
+300
| +21% | +$4.56K | 0.01% | 391 |
|
|
2023
Q4 | $24.4K | Buy |
1,428
+200
| +16% | +$3.42K | 0.01% | 401 |
|
|
2023
Q3 | $10.3K | Buy |
1,228
+63
| +5% | +$527 | 0.01% | 509 |
|
|
2023
Q2 | $28.9K | Hold |
1,165
| – | – | 0.01% | 318 |
|
|
2023
Q1 | $17.5K | Hold |
1,165
| – | – | 0.01% | 396 |
|
|
2022
Q4 | $13.8K | Buy |
1,165
+200
| +21% | +$2.37K | 0.01% | 375 |
|
|
2022
Q3 | $6K | Buy |
965
+90
| +10% | +$560 | ﹤0.01% | 462 |
|
|
2022
Q2 | $4K | Buy |
875
+200
| +30% | +$914 | ﹤0.01% | 486 |
|
|
2022
Q1 | $6K | Buy |
+675
| New | +$6K | ﹤0.01% | 439 |
|